J. Goldman & Co’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
ACM
SPM
LK
XT
J. Goldman & Co's PYPD Position: Q1 2026 in Review
J. Goldman & Co reduced its PolyPid (PYPD) stake by 13% in Q1 2026, selling an estimated $101K and leaving 149,499 shares worth $655K. The position accounts for 0.02% of the portfolio, ranked #478.
J. Goldman & Co first reported a position in PYPD in Q4 2024 and has held it in 6 quarters since. The position peaked at $748K in Q4 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.
- J. Goldman & Co held 149,499 shares of PolyPid worth $655K as of Q1 2026.
- J. Goldman & Co sold 22,811 PolyPid shares in Q1 2026, an estimated $101K.
- PolyPid made up 0.02% of J. Goldman & Co's portfolio in Q1 2026, its #478 holding.
- J. Goldman & Co first reported a position in PolyPid in Q4 2024 and has held it in 6 quarters since.
- J. Goldman & Co's PolyPid position peaked at $748K in Q4 2025.
- 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.
Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.